A Randomized, Placebo ‐Controlled Phase I Trial of Live, Attenuated Herpes Zoster Vaccine in Subjects with End Stage Renal Disease Immunized Prior to Renal Transplantation

ConclusionsThe data suggest that the shingles vaccine is safe in subjects with ESRD awaiting transplant. Antibody responses were similar to those seen previously in adults >50 years of age and are consistent with a protective response.This article is protected by copyright. All rights reserved.

Source: Transplant Infectious Disease - March 7, 2018 Category: Transplant Surgery Authors: Geraldine Miller, Heidi Schaefer, Sandra Yoder, Rachel Miller, Patricia Winokur, Karen Kotloff, David Klassen, Michael Wierzbicki, Cyrille Amegashie, Kathryn Edwards Tags: Original Report Source Type: research